Yuyue Medical Announces Participation in Establishing AstraZeneca CICC Healthcare Venture Investment Partnership with RMB 200 Million Commitment

Original Title:Yuwell: Plans to participate in the investment and establishment of the AstraZeneca CICC Medical Venture Capital Partnership, with a maximum fund size of RMB 2.5 billion, of which the company will contribute RMB 200 million. Source: Caitong Society

[Yuwell: Plans to Participate in the Investment and Establishment of the AstraZeneca CICC Medical Venture Capital Partnership, with a Maximum Fund Size of RMB 2.5 Billion; the Company Will Contribute RMB 200 Million.] Yuwell: Plans to participate in the investment and establishment of the AstraZeneca CICC Medical Venture Capital Partnership, with a maximum fund size of RMB 2.5 billion; the company will contribute RMB 200 million.